Contact Us
CN EN
Synesis SynBio Platform
What is Synthetic Biology?
The term "Synthetic Biology" can be traced back to a 1913 paper by W.A.D. in Nature titled "Synthetic Biology and the Mechanisms of Life." Over a century of development, its meaning has diverged significantly from the original concept. In 2000, at the American Chemical Society Annual Meeting, Stanford University’s Kool defined synthetic biology as “the use of the synthetic capabilities of organic chemistry and biochemistry to design non-natural synthetic molecules that perform functions in biological systems.” Today, there are many similar definitions of synthetic biology. For example, Zhang Xian'en, a fellow of the American Institute of Medicine and Biological Engineering, described it as: "Synthetic biology, based on biological sciences, converges disciplines such as chemistry, physics, and information science, integrates engineering principles, designs and modifies natural or synthetic organisms, reveals the laws of life (creation for knowledge), and transforms biological systems for engineering applications (creation for use)."
Guided by basic theoretical principles, synthetic biology employs a "bottom-up" engineering approach, develops enabling technologies, and addresses challenges in the standardization and rational design of biological systems for engineering applications. Its academic system primarily encompasses basic theory, enabling technologies, and innovative applications. Meanwhile, the development of synthetic biology should also focus on the appropriate policy environment, ethical, legal, and regulatory frameworks, and emphasize public engagement and science outreach.

Through the reconstruction of metabolic pathways and the design of cell factories, synthetic biology can:

1.
Disrupt the traditional methods of obtaining plant-based raw materials, such as those used in plant medicines and nutritional supplements, by designing synthetic routes for natural plant products.
2.
Replace traditional chemical synthesis routes and promote the green production of pharmaceuticals and chemical products.
3.
Build on traditional food manufacturing technologies to enable the synthetic biological production of future functional foods.

Synthetic Biology

is widely regarded as one of the disruptive scientific and technological advancements that will change the future, with the potential to lead a new industrial revolution.

In Environmental Technology

synthetic biology can design powerful metabolic pathways to degrade persistent organic pollutants.

In Medicine

it may offer better diagnostic and therapeutic solutions for genetic and complex diseases, and offer customized tissues and organs for regenerative medicine.

In Information Technology

it can develop DNA storage technology, breaking through the limitations of existing storage technologies.

In Ecology

it can help protect and restore, rather than destroy, biological systems.

In Chemical Engineering

it may provide solutions for the efficient conversion of abundant, low-quality biomass, enabling sustainable green energy and a circular economy.

Core Technological Advantages
Leveraging the powerful gene synthesis ability of our parent company, GenScript, Bestzyme’s Synesis Synthetic Biology R&D platform enables the rapid and large-scale synthesis of target genes, providing strong support for the construction and screening of mutation libraries. In the field of strain modification and gene editing, Bestzyme has established several efficient and rapid gene editing techniques, including CRISPR technology, as well as a visualized positive transformation screening method. These technologies enable rapid and efficient modification of different host strains.
R&D Hardware
In strain construction and analysis, Bestzyme owns high-throughput platform equipment for plasmid extraction, transformation, strain screening, and automatic enzyme activity testing. Additionally, the company has sample analysis equipment such as high-performance liquid chromatography (HPLC), ion chromatography, and high-precision viscosity meters.
Industrial Scale-up
After years of R&D accumulation, Bestzyme has established fermentation and extraction process control models for various platform strains, including Aspergillus niger and Bacillus subtilis, enabling the rapid development of fermentation and extraction formulations and process scaling that meet large-scale production requirements. Bestzyme's process development platform primarily focuses on the development of fermentation and extraction processes, and has successfully developed and scaled production for over 20 types of feed and industrial enzymes. These experiences from R&D to production provide significant technological advantages and accelerate the speed of process development for Bestzyme's R&D projects, enabling faster commercialization of related products.
Efficient Expression Platform
Platform strains are one of the core technologies in synthetic biology and the bio-fermentation industry. After over a decade of continuous optimization and accumulation, Bestzyme has established five major strain platforms that meet food safety standards: Aspergillus niger, Aspergillus oryzae, Pichia pastoris, Bacillus subtilis, and Bacillus licheniformis. These platforms are supported by a comprehensive expression element library.
The GRAS-certified expression platform from Bestzyme meets the protein expression needs for various proteins and industrial-scale production.

Bacillus subtilis

1.Gram-positive bacteria, FDA-certified GRAS strains

2.Used for efficient expression of amylase, protease, pullulanase, etc.

Bacillus licheniformis

1.Gram-positive bacteria, FDA-certified GRAS strains

2.Used for efficient expression of amylase, protease, glucanase, etc.

Aspergillus niger

1.FDA-certified GRAS strains

2.Used for efficient expression of phytase, xylanase, glucoamylase, etc.

Aspergillus oryzae

1.FDA-certified GRAS strains

2.Used for efficient expression of proteases, lipases, amylases, etc.

Pichia pastoris

1.FDA-certified GRAS strains

2.Used for efficient expression of amylases, proteases, xylanases, etc.

AI-Driven Innovation
Bestzyme's Synesis Synthetic Biology Platform combines advanced AI algorithms with an automated experimental platform and expert experience. This integrated system has developed a comprehensive enzyme engineering, synthetic biology research, and evaluation framework, enabling more efficient and cost-effective exploration of protein sequence space. It significantly reduces the number of wet-lab experiments, accelerating the dry-wet cycle of protein engineering.
  • AI accelerates protein design and optimization in enzyme engineering and synthetic biology.
  • It helps overcome traditional limitations and discover novel optimization solutions.
  • Combined with high-throughput experiments, AI boosts R&D efficiency.
In the future, as AI technology advances, we will continue to explore its potential in protein engineering, driving breakthroughs in enzyme modification and synthetic biology and ushering in a new era of sustainable development.
Learn More

Synesis Syn-Bio Platform

Creating cellular factories to catalyze infinite possibilities.

More

Sustainability

Biotechnology Leading a Sustainable Future

More

About Us

Using biotechnology to make humans and nature healthier

More